Modification of the operating microscope.

J. Aquavella,G. K. Jackson

DOI: https://doi.org/10.1016/0002-9394(70)90902-5

1970-10-01

Abstract:

What problem does this paper attempt to address?

Diagnostic delay in inflammatory bowel diseases in children

Marina O. Prokhorenkova,Kristina M. Nosenko,Mariya A. Orlova,Anna V. Vinokurova,Vlada A. Kazakova,Olga A. Koroleva,Anton Yu. Dorogov,Alexandr S. Potapov

DOI: https://doi.org/10.46563/1560-9561-2023-26-6-399-407

2023-12-27

Russian Pediatric Journal

Abstract:Introduction. The incidence and prevalence of inflammatory bowel disease (IBD) in children is increasing steadily. The diagnosis is often delayed that can lead to an increased risk of complications and significantly decrease the quality of life in the child. The identification of reasons associated with prolonged diagnostics must bring down healthcare costs, reduce the frequency of surgical interventions and use of biological agents. The aim of our study was to determine the duration of diagnosis and associated factors in IBD children. Materials and methods. The research held at the National Medical Research Center for Children’s Health included the analysis of three hundred sixty four medical records of children diagnosed with ulcerative colitis (UC) or Crohn’s Disease (CD). This investigation assessed the time of onset of the first symptoms, the first visit to a doctor, the time of establishing the diagnosis, and the first symptoms. The diagnostic time and delay for all IBD were determined. Results. The study included 286 patients, including 157 CD and 129 UC. The diagnostic delay was 18 months for CD, and 6 months for UC. The manifestation of the disease with extraintestinal symptoms in CD was found to increase the chance of a diagnosis duration of more than 18 months by 8.88 times (95% CI 3.4–23.06, p < 0.001), and in UC — more than 6 months by 4.98 times (95% CI 1.52–16.3, p = 0.009). Moreover, the absence of liquid stools, blood in the stool, low-grade fever, and abdominal pain in CD can lead to an increase in diagnostic time. It was also found that UC boys are diagnosed much longer. Conclusion. CD requires more time to make a diagnosis than UC, which is due to the peculiarity of the clinical course of the disease. Despite the fact that a doctor has consulted patients in time, a delay in establishing a diagnosis occurred at the examination stage, so that requires additional alertness from the specialist’s side.
Travel Time to Treating Center is Associated with Diagnostic Delay in Pediatric Inflammatory Bowel Disease

Joi F McLaughlin,Tiffany Linville,Traci W Jester,Tuvia A Marciano,Farrah Lazare,Jennifer L Dotson,Charles Samson,Barbara Niklinska-Schirtz,Jose Cabrera,Ian Leibowtiz,Suruchi Batra,Rana Ammoury,Jennifer A Strople,Shehzad Saeed,Kelly C Sandberg,Jeanne Tung,Sofia G Verstraete,Ryan F Cox,Sera Na,Steven J Steiner,Sabina A Ali,Esther J Israel,Jill Dorsey,Jeremy Adler,Yuliya Rekhtman,Matthew D Egberg,Emmala Ryan Waduge,Jen Savas,Colleen M Brensinger,James D Lewis,Michael D Kappelman

DOI: https://doi.org/10.1016/j.cgh.2024.07.027

2024-08-22

Abstract:Background and aims: Delayed diagnosis of inflammatory bowel disease (IBD) leads to prolonged symptoms and worse long-term outcomes. We sought to evaluate whether race, ethnicity, disease type, and social factors are associated with delayed diagnosis of pediatric IBD. Methods: We performed a cross-sectional study of newly diagnosed pediatric patients with IBD at 22 U.S. sites from 2019-2022. Parents/guardians reported race, ethnicity, time between symptom onset and diagnosis, and other social determinants of health. Through bivariate and multivariable analyses using generalized estimating equations we evaluated associations between these factors and diagnosis time defined as ≤60 days, 61-180 days, 181-365 days and >365 days. Results: We enrolled 869 participants (mean age at diagnosis 13.1 years, 52% male, 57% Crohn's disease (CD), 34% ulcerative colitis (UC), 8% Hispanic, 30% non-White). Overall, the mean time to diagnosis was 265.9 days. After adjustment, factors associated with longer diagnosis time included CD vs. UC (OR 2.6, 95% CI 1.9-3.5), 2 or more other health conditions (OR 1.7, 95% CI 1.1-2.7), and longer travel time to clinic [(> 1 hour (OR 1.7, 95% CI 1.2-2.4), > 2 hours (OR 1.8, 95% CI 1.2-2.9) each vs<30 minute]. There was no association with race, ethnicity, birth country, gender, parent education, household income, insurance type, health literacy, and health system distrust. Conclusions: Consistent with prior literature, diagnostic delay is longer for CD than UC. Reassuringly, time to diagnosis is equitable across racioethnic groups. New models of diagnostic care are needed for communities affected by longer travel times.
Anaesthetic premedication: aims, assessment and methods.

T. Madej,R. Paasuke

DOI: https://doi.org/10.1007/BF03015163

1987-05-01

Abstract:
Survival of Staphylococcus epidermidis on the skin of patients of lepromatous leprosy.

B. Kumar,V. Khanna,M. Saxena,S. Sharma

DOI: https://doi.org/10.1111/J.1365-2672.1988.TB02437.X

1988-06-01

Journal of Applied Bacteriology

Abstract:The effect of hydration on Staphylococcus epidermidis, the predominant resident bacterial flora, was studied on skin affected by leprosy and known to have impaired sweating. Normal areas served as control. Significantly higher bacterial counts were observed in affected areas compared with normal-looking skin in 16/19 of the patients. Artificial application of Staph. epidermidis on leprosy-affected and unaffected areas, however, showed equivocal results, as in only 50% of the patients were higher counts obtained in affected compared with unaffected sites. The possible responsible factors for the present observation are discussed.
P1108 Factors Associated with Delayed Diagnosis of Inflammatory Bowel Disease and Risk of Complications: Analysis of the Brazilian National Registry

A Ribas Andrade,R Froes,L Sassaki,M Faria,J M Parente,G Bezerra,P Pertence,R Kaiser,G Zabot,J Feldmann,C H Santos,C Chiquetti,N Almeida,F Fortes,A Maia,R Parra,G Santana,M C Lopes,V Salgado,B Carvalho,M Bafutto,S Araújo,H Souza,F L Maximiano,C Nascimento,R Saad-Hossne,C Flores,R Kaiser Junior

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1238

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background The Brazilian Organization for Crohn's Disease and Colitis (GEDIIB) has established a national registry of inflammatory bowel disease (IBD). Timely diagnosis and treatment of the disease are crucial to mitigate the risk of complications in this patient population. Therefore, this study aimed to assess the variables associated with delayed diagnosis and the frequency of complications in IBD patients in Brazil. Methods A cohort study was conducted from August 2020 to August 2023. Data were obtained from medical records and patient consultations using the REDCap platform, with approvals from the ethics boards of participating institutions. Patients were categorized based on the time from symptom onset to diagnosis: < 1 year, 1 to 1 year 11 months, and ≥ 2 years. Socioeconomic and clinical data, such as disease extension, use of biological therapy, and complications like the need for surgery or hospitalization, were evaluated. Results The study included 2,436 patients, with 1,147 diagnosed with ulcerative colitis (UC) and 1,289 with Crohn's disease (CD). Of these, 62% were managed in public centers, and 38% in the private system. The age at diagnosis was 38 ± 15.5 years for UC and 33.7 ± 14.9 years for CD, with females predominating (64.5% for UC and 53.4% for CD). Among UC patients, disease extension included pancolitis (43.5%), left colitis (28.8%), and proctitis (27.7%). The time between symptom onset and diagnosis was longer in CD patients (p<0.001), as follows: < 1 year (UC 58.4% and CD 50.9%), 1 to 1 year 11 months (UC 22.3% and CD 21.1%), and ≥ 2 years (UC 19.3% and CD 28%). The shortest interval in UC patients was observed in private services (p<0.001), Southern and Northeastern regions of Brazil (p<0.001), and in patients without extraintestinal manifestations (EIM) (p=0.003). No differences were noted regarding disease extent, need for surgery, hospitalization, presence of cancer, or use of biological therapy. In CD patients, the shortest interval was observed in private services (p<0.001), the Southern region of Brazil (p<0.001), and was associated with a lower rate of hospitalization due to complications or disease activity (p=0.032). Among those who underwent surgery (35.6%), patients operated on in a public university hospital experienced a greater delay in diagnosis (p=0.014). No differences were observed regarding the presence of perianal disease, need for surgery, cancer, or use of biological therapy. Conclusion The window of opportunity is imperative to reduce complications, especially in CD. Further epidemiological studies are needed to shape national public health policies, emphasizing early diagnosis and appropriate treatment of IBD.

gastroenterology & hepatology
A Shortened Diagnostic Interval and Its Associated Clinical Factors and Related Outcomes in Inflammatory Bowel Disease Patients from a Cohort Study in China

Runing Zhou,Xiyu Sun,Mingyue Guo,Huimin Zhang,Xuanfu Chen,Meixu Wu,Haozheng Liang,Xiaoyin Bai,Gechong Ruan,Hong Yang

DOI: https://doi.org/10.2147/jir.s434673

IF: 4.5

2024-01-19

Journal of Inflammation Research

Abstract:Runing Zhou, 1 Xiyu Sun, 2 Mingyue Guo, 1 Huimin Zhang, 1 Xuanfu Chen, 1 Meixu Wu, 1 Haozheng Liang, 1 Xiaoyin Bai, 1 Gechong Ruan, 1 Hong Yang 1 1 Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China; 2 Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China Correspondence: Hong Yang, Department of Gastroenterology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing Street, Beijing, 100730, People's Republic of China, Tel +86-10-69155014, Email Aim: The diagnosis of inflammatory bowel disease (IBD) worldwide is complicated and results in diagnostic delay. However, the diagnostic interval of IBD and the factors associated with diagnostic delay in patients in China have not been determined. Methods: We retrospectively analyzed clinical data of hospitalized IBD patients in Peking Union Medical College Hospital from January 1998 to January 2018. Patients were divided into non-delayed and delayed groups according to their diagnostic interval. Results: A total of 516 and 848 patients were confirmed to have Crohn's disease (CD) and ulcerative colitis (UC), respectively. The median diagnostic intervals were 6 and 20 months in patients with UC and CD, respectively ( P < 0.05). A decreasing trend in the diagnostic interval for IBD was observed over time, from 9 months to 1 month in UC patients and from 30 months to 3 months in CD patients. The longest diagnostic interval was 29.5 months in CD patients with first symptoms at the age of 51– 60 years and 12.5 months in UC patients at the age of 41– 50 years. In patients with CD, intestinal obstruction (OR=2.71), comorbid diabetes (OR=4.42), and appendectomy history (OR=2.18) were risk factors for diagnostic delay, whereas having fever as the first symptom may reduce its risk (OR=0.39). In patients with UC, the misdiagnosis of chronic enteritis (OR=2.10) was a risk factor for diagnostic delay. Conclusion: The diagnostic interval for IBD has decreased over the years. Some clinical manifestations, such as initial symptoms and age at symptom onset, may help to shorten this interval. Diseases such as tuberculosis and infectious enteritis should be considered during differentiation. Keywords: inflammatory bowel disease, diagnostic delay, China Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is a relapsing chronic inflammatory disorder of the gastrointestinal tract. Its specific etiology is unknown but it possibly involves genetic, immunological, and environmental factors. 1 The diagnosis of IBD is a complicated task worldwide, and the number of factors contributing to this disease and possibly causing diagnostic delay (DD) in a considerable number of IBD patients. According to a summary by Gottfried et al from Austria, 2 the median diagnostic interval varied from 3 months to 7 years and from 1 month to 1 year in CD and UC patients, respectively. In China, IBD is not a common gastrointestinal disease and has atypical symptoms, physical signs or a lack of sufficient attention. The diagnosis of IBD relies on a combination of clinical, biochemical, stool, endoscopic, and cross-sectional imaging findings; histological investigations; and the exclusion of infectious enteritis. Follow-up for at least six months or one year is essential when the diagnosis is doubtful. A few diseases, such as intestinal tuberculosis (ITB), infectious enteritis, and Behçet's disease (BD), mimic the manifestations of IBD and are endemic in China, posing a major challenge in differential diagnosis. 2,3 Several studies have reported that DD worsens the prognosis of IBD patients. Two Korean studies revealed that DD increased not only the risk of intestinal surgery by 2.54-fold and 6.81-fold in CD and UC patients, respectively, but also the risk of intestinal stenosis or perianal fistula in CD patients. 4,5 Moreover, DD may delay the proper treatment of IBD patients, as some medications may have better efficacy in newly diagnosed patients. Therefore, identifying risk factors for DD at an early stage is important. As an emerging disease in China, IBD has a growing incidence trend, and several studies have reported notable differences in its clinical characteristics compared to West. 2 For example, there was a male predominance of CD in China, and less family clu -Abstract Truncated-

immunology
P302 Diagnostic Delayed is Associated with a Poor Prognosis in Patients with Crohn's Disease

V Kiliç,F Kivrakoglu,M Ergin,H Kucuk,I Yuksel

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0432

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background The studies show that diagnostic delay, especially in Crohn’s disease (CD), is associated with a higher risk of complications and major surgery. We aimed to investigate timing of the diagnostic delay (DD) and its impact on the CD outcomes. Methods We retrospectively evaluated demographic and clinical features of CD patients between June 1993 and October 2023. Diagnostic delay was defined as the time interval from the onset of the first symptoms to the making of the CD diagnosis. The first CD related symptoms were evaluated by a review of the physician’s notes and medical record. Specific symptoms of CD included chronic or recurrent bloody or non-bloody diarrhea, and/or abdominal pain accompanied by noticeable weight loss, general weakness, and fever. Results 514 patients with CD were included in the study. The median age of disease onset was 34.14 years (16–84 years). Male sex was 299 (58.2%). DD was detected median 13 months (5-47) (14 months in male and 12 months in female). DD was 12 months for diseases with onsets before the age of 40 and 15 months for diseases with onsets after the age of 40. DD was 25 months in isolated ileal involvement, in terminal ileal involvement was 21.5 months, ileo-colonic involvement was 20 months, and colonic location was 10 months. Ileal involvement was found to have a longer duration for DD than colonic involvement. Compared to stenosing behavior (20 months) and penetrating behavior (17 months), DD was shorter in non-stenosing non-penetrating behavior (12 months). DD was longer in perianal disease (18 months) than in those without (12 months). Current smokers had a longer duration of the DD (20 months) compared to non-smokers (11.5 months) and ex-smokers (10 months). The duration of DD (18 months) was longer in CD patients with extraintestinal manifestations than in those without (12 months). Regarding the biological treatment, CD patients who experienced multiple biologics and resistance had longer DD (24 months) than those who experienced biologic monotherapy and responded (12 months). Compared to patients who had not had surgery (12 months), DD was longer in CD patients who had undergone surgery (15 months). Conclusion Our study showed that ileal involvement, stenosing-penetrating behavior, perianal disease, current smoking and existing extraintestinal manifestations were connected with DD. DD was also associated with multiple biologic needed and surgery. DD may have a role a significantly increased risk of bowel damage.

gastroenterology & hepatology
P1127 Diagnostic delay and economic burden in IBD: a multicenter italian experience in patients treated with biologics

G Mocci,G Orrù,F M Onidi,G Bodini,M Picchio,A Ferronato,C Zampaletta,M Corpino,R Lorenzetti,P Usai Satta,W Elisei,A Tursi

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1257

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background Inflammatory bowel diseases (IBDs), Crohn's disease (CD) and ulcerative colitis (UC), are chronic and immune-mediated diseases with a relapsing-remitting trend. The overall incidence of these diseases is increasing. However, it is estimated that more than one third of patients experienced symptoms for more than one year before diagnosis. Delay in IBD diagnosis has several clinical, therapeutic and economic implications. Early diagnosis and proper treatment are the cornerstones for improving the standard of care for these patients. This study aims to evaluate the diagnostic delay (DD) in patients with IBD and to analyze the clinical burden of the delay in IBD diagnosis in patients treated with biological drugs. Methods An observational and retrospective study was performed in IBD patients, regularly followed in four IBD Units. Data regarding delay in IBD diagnosis were assessed through a questionnaire evaluating the disease course. Moreover, data about biologics dispensation were obtained from the medical records in the period 2020-2022 Results 344 IBD patients were enrolled (UC 228, CD 116, M 198, F 146). Median age at diagnosis was 42 years (IQR 9-82); Median DD was 12 months (IQR: 6-24). No significant difference was found in median DD between UC [12 months (IQR: 4.5-12.0)] and CD patients [12 months (IQR: 12-48)]. However, the proportion of patients with a DD >24 months was significantly (p=0.007) higher in CD (41/110 = 37,3%) than in UC patients (20/220=9%). After a median disease duration of 10 years (IQR: 4-17), overall, 164 patients (49.7%) were exposed to one biologic agent, 105 patients (31.8%) were exposed to two biologic agents, 61 (18.5%) to three or more biologic agents. 18,5% of patients (61/330) underwent surgery. The statistical analysis showed that DD >24 months was not statistically significant associated with history of ≥ 2 biological drugs (p=0.51). Conversely, there was association with surgical treatment (p=0.004). Conclusion The diagnostic delay in IBD represents a challenge with clinical and, therapeutic impact. It’s crucial to cooperate with general practitioner and gastroenterologists not dedicated to IBD in order to reduce the diagnostic delay and guarantee an effective, appropriate and early treatment that will improve the patients’ quality of life and meanwhile reduce the health care system costs.

gastroenterology & hepatology
Diagnostic Delay in Crohn's Disease is Associated with Increased Rate of Abdominal Surgery: A Retrospective Study in Chinese Patients.

Yuan Li,Jianan Ren,Gefei Wang,Guosheng Gu,Xiuwen Wu,Huajian Ren,Zhiwu Hong,Dong Hu,Qin Wu,Guanwei Li,Song Liu,Nadeem Anjum,Jieshou Li

DOI: https://doi.org/10.1016/j.dld.2015.03.004

IF: 5.165

2015-01-01

Digestive and Liver Disease

Abstract:Background: Diagnostic delay of Crohn's disease presents a challenge, and may increase the abdominal surgery rate. There have been no reports regarding diagnostic delay in Chinese patients.Aims: We aimed to evaluate the impact of diagnostic delay on outcomes of Chinese Crohn's disease patients, and identify potential risk factors for the delay.Methods: Altogether, 343 Crohn's disease patients from our hospital were retrospectively included. We assessed the effects of diagnostic delay on the outcomes, and identified the underlying risk factors.Results: Diagnostic interval was defined as the interval between the first symptoms and the diagnosis of Crohn's disease. Diagnostic delay was defined according to the time interval in which the 76th to 100th percentiles of patients were diagnosed. The rates of subsequent surgery for diagnostic-delay and non-diagnostic-delay patients were 84.7% and 62.4%, respectively (odds ratio = 1.108, P < 0.0001). We found statistical differences between the two groups regarding age >40 years at diagnosis (35.3% versus 18.2%, P = 0.004), basic educational level (48.2% versus 30.6%, P = 0.005), and no family history of Crohn's disease (0 versus 1.6%, P = 0.045).Conclusions: Diagnostic delay of Crohn's disease was significantly associated with increased rates of intestinal surgery. Risk factors for diagnostic delay were age >40 years at diagnosis, basic educational level, and no family history of Crohn's disease. (C) 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
P1172 Epidemiology and initial presentation of newly diagnosed inflammatory bowel diseases in a Danish population-based inception cohort – results from the IBD Prognosis Study

M Attauabi,G Roager Madsen,F Bendtsen,J Seidelin,J Burisch

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1302

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background It is unclear whether the incidence of inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), continues to increase. In this study, we aimed to investigate the occurrence and initial disease presentation of IBD in a population-based setting. In addition, we aimed to identify predictors of an early severe disease presentation. Methods The study was conducted as part of IBD Prognosis Study, an ongoing Danish prospective population-based inception cohort study that includes incident patients with IBD according to the Copenhagen Diagnostic Criteria since May 2021, covering the catchment areas of approximately 20% of the Danish population (1.1 million). In this analysis, cutoff for data analysis was in May 2023. Crude incidence rates and European Standard Population (ESP)-adjusted rates were calculated. A multivariable logistical regression model was constructed to identify predictors of a severe disease presentation, defined as the composite need for systemic steroids, immunomodulators, biologics, or IBD-related surgery within three months of disease. Results In total, 554 patients (UC: 344, CD: 210) fulfilled the inclusion criteria, resulting in the following crude incidence rates per 100,000 person-years: IBD 23.4 (95% CI 21.5-25.4), UC 14.0 (12.6-15.6), and CD 8.6 (7.4-9.8). ESP-adjusted rates were: IBD 20.4 (18.2-22.9), UC 11.8 (10.2-13.0), and CD 7.9 (6.5-9.9) (Figure 1). Among patients with UC, 81 (26.3%) and 95 (30.8%) had left-sided or extensive colitis at disease onset, respectively, while 61 (30.3%) and 62 (30.8%) patients with CD had ileal or ileocolonic disease. Stricturing or penetrating CD behaviour was observed in 24 (11.9%) and 11 (5.5%) patients, respectively. A high proportion of patients needed hospitalization (CD: 68 (33.8%), UC: 60 (19.5%), p=0.001) and IBD-related surgery (CD: 21 (10.4%), UC: 10 (3.2%), p=0.004) at the time of diagnosis. In multivariable analysis, a severe disease presentation of UC at the time of diagnosis was associated with left-sided or extensive disease distribution, thrombocytosis, and increased levels of C-reactive protein (CRP) (Table 1). In patients with CD, stricturing, or perianal disease, as well as anemia, levels of albumin, CRP, and calprotectin were predictive of this endpoint (Table 1). Conclusion The incidence of UC and CD in Denmark appears stable compared to historical data from the previous decades.1 The study identified clinical predictors of a severe disease presentation from the time of diagnosis, emphasizing the critical need for early risk stratification and intervention strategies. Reference: 1 Dorn-Rasmussen M et al., J Crohns Colitis. doi: 10.1093/ecco-jcc/jjac138.

gastroenterology & hepatology
Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences

G. Hudelist,N. Fritzer,A. Thomas,C. Niehues,P. Oppelt,D. Haas,A. Tammaa,H. Salzer

DOI: https://doi.org/10.1093/humrep/des316

IF: 6.1

2012-09-17

Human Reproduction

Abstract:STUDY QUESTION: What is the length of the diagnostic delay for endometriosis in Austria and Germany, and what are the reasons for the delay?SUMMARY ANSWER: The diagnostic delay for endometriosis in Austria and Germany is surprisingly long, due to both medical and psychosocial reasons.WHAT IS KNOWN ALREADY: Diagnostic delay of endometriosis is a problematic phenomenon which has been evaluated in several European countries and in the USA, but has not been reported for Germany and Austria.STUDY DESIGN, SIZE, DURATION: A cross-sectional, questionnaire-based multicentre study was conducted in tertiary referral centers in Austria and Germany. From September 2010 to February 2012, 171 patients with histologically confirmed endometriosis were included.PARTICIPANTS, SETTING, METHODS: Patients with a previous history of surgically proven endometriosis, internal diseases such as rheumatic disorders, pain symptoms of other origin, gynecological malignancy or post-menopausal status were excluded from the analysis. Patients with histologically confirmed endometriosis completed a questionnaire about their psychosocial and clinical characteristics and experiences. Of 173 patients, two did not provide informed consent and were excluded from the study.MAIN RESULTS AND THE ROLE OF CHANCE: The median interval from the first onset of symptoms to diagnosis was 10.4 (SD: 7.9) years, and 74% of patients received at least one false diagnosis. Factors such as misdiagnosis, mothers considering menstruation as a negative event and normalization of dysmenorrhea by patients significantly prolonged the diagnostic delay. No association was found between either superficial and deep infiltrating endometriosis or oral contraceptive use and the prolongation of diagnosis.LIMITATIONS AND REASONS FOR CAUTION: There was a possible selection bias due to inclusion of surgically treated patients only.WIDER IMPLICATIONS OF THE FINDINGS: Several factors causing prolongation of diagnosis of endometriosis have been reported to date. The principal factors observed in the present study are false diagnosis and normalization of symptoms. Teaching programs for doctors and public awareness campaigns might reduce diagnostic delay in Central Europe.STUDY FUNDING/COMPETING INTEREST(S): No competing interests exist.

obstetrics & gynecology,reproductive biology
P1167 Inflammatory Bowel Disease: a phenome-wide pre- and post-diagnostic association study

A Ebert,R Elmahdi,G Poulsen,M Bøgsted,B Verstockt,C Lees,T Jess

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1297

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is known to be associated with various extra-intestinal manifestations, impacting organ systems beyond the gastrointestinal tract. Identifying comorbidities in IBD and the timing of their development can provide valuable insight into the mechanisms underlying IBD development. Methods We conducted the first population- and disease-wide phenomic association study in IBD, using >6 million ICD-10 coded healthcare contacts from 10 years before and up to 17 years after IBD diagnosis to investigate associations with 1583 diseases. To explore co-morbidities with potential aetiological significance with IBD, we additionally assessed the strength of association with all diseases in the pre-diagnostic compared with the post-diagnostic period. To correct for multiple testing, we adjust our significance threshold (p<0.05) with the Bonferroni correction, resulting in an adjusted p-value of 7.90×10, which we refer to as disease-wide statistical significance. Results We identified 312 disease-wide statistically significant associations with 125 of these diseases appearing up to 10 years before diagnosis. The risk of immune-mediated diseases and extra-intestinal manifestations are among those diseases increased up to 10 years prior to IBD diagnosis (psoriasis: CD-RR: 2.57, 95% CI: 2.00-3.29; UC-RR: 1.54, 95% CI: 1.25-1.87; enteropathic arthropathies: CD-RR: 3.57, 95% CI: 2.65-4.78; UC-RR: 1.8, 95% CI: 1.38-2.32). This was also the case for gastroenterological and liver disorders (gall stones: CD-RR: 1.82, 95% CI: 1.62-2.04; UC-RR: 1.26, 95% CI: 1.15-1.37; acute pancreatitis: CD-RR: 1.83, 95% CI: 1.30- 2.53; UC-RR: 2.27, 95% CI: 1.84-2.79). The risk of cardiometabolic diseases and neuropsychological disorders had increased disease-wide statistical significance both pre- and post-diagnostically, whereas potential sequelae of treatment, such as osteoporosis (CD-HR: 2.56, 95% CI: 2.30-2.86; UC-HR: 1.92, 95% CI: 1.79-2.07) or herpes simplex infections (CD-HR: 4.04, 95% CI: 2.76-5.91; UC-HR: 1.69, 95% CI: 1.2-2.38) were primarily seen post-diagnostically. Of potential aetiological importance to CD, diagnosis with infectious mononucleosis (RR: 1.87, 95% CI: 1.37-2.52) was significantly associated with the pre- compared to the post-diagnostic period. Conclusion Our results demonstrate IBD as an essentially multisystemic disease, particularly manifesting as gastrointestinal, metabolic, immune, and neuropsychological disorders, present up to 10 years prior to IBD diagnosis. Infectious diseases of aetiological interest identified warrant further investigation.

gastroenterology & hepatology
High Incidence and Morbidity of Clostridium Difficile Infection among Hospitalized Patients with Inflammatory Bowel Disease: A Prospective Observational Cohort Study

Xiao Li Chen,Jing Deng,Xin Chen,Shan,Yu Wang,Qian Cao

DOI: https://doi.org/10.1111/1751-2980.12798

2019-01-01

Journal of Digestive Diseases

Abstract:ObjectiveTo investigate the clinical features of Clostridium difficile infection (CDI) in hospitalized patients with inflammatory bowel disease (IBD) and to analyze the impact of CDI on IBD.MethodsA prospective study on patients newly diagnosed with IBD was conducted at the IBD center at Sir Run Run Shaw Hospital from March 2015 to May 2016. Stool samples for anaerobic culture and polymerase chain reaction were used to test CDI and to detect the different toxins in the groups. The patients were followed up for 2 years.ResultsAltogether 230 patients with IBD were enrolled, including 77 with ulcerative colitis (UC) and 153 with Crohn's disease (CD). The incidence rate of CDI was 13.9% (32/230). Patients with UC were more susceptible to CDI than those with CD (24.7% vs 8.5%, P < 0.01). Among UC patients, a long disease course, prior hospitalization, proton pump inhibitor use, and disease severity were associated with an increased risk of CDI (all P < 0.05). CDI prolonged hospital stay and increased the rate of long‐term surgery rate in UC (both P < 0.05). Among patients with CD, CDI increased both short‐ and long‐term surgery rates during the 2‐year follow‐up (P < 0.05) and increased repeated hospitalization in the follow‐up study (odds ratio 2.41, P = 0.02).ConclusionsA high incidence rate of CDI in patients hospitalized with IBD was related with longer hospital stay and higher surgery rates in our center. Patients with UC are more vulnerable to CDI than those with CD.
P1128 Reducing diagnostic delay of Extra-Intestinal Manifestations in patients with Inflammatory Bowel Disease: a comparative study between a multidisciplinary immune-mediated diseases outpatient clinic and conventional referral specialists

O M Nardone,G Calabrese,R Peluso,F Foglia,M Megna,S Cacciapuoti,A La Mantia,E D'Alessandro,M Ferrante,G Villani,A Testa,L Bonacci,C Leo,A Rispo,F Castiglione

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1258

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background Extraintestinal manifestations (EIMs) can occur in up to 47% of patients diagnosed with inflammatory bowel disease (IBD); hence the early detection of EIMs in IBD patients is crucial to prevent structural damage. However, there is a substantial variation in the reported time to diagnosis of EIMs due to a lack of a standardised approach. We, therefore, evaluated the length of time to diagnose EIMs through an integrated immune-mediated diseases (IMIDs) outpatient clinic (IMID-C) compared to a standard outpatient clinic (SO-C). Secondary endpoint included the impact of diagnostic time on the time to therapy, thereby aiming for an early control of disease Methods We conducted a single-centre cohort observational study including IBD patients ≥18 yo presenting red flags for EIMs who underwent outpatient visits through a multidisciplinary IMIDs clinic between 2018-2022 and we compared this group to a historical cohort, with similar clinical features, who underwent conventional visits by individual referral specialists from 2017 to 2022. Diagnostic delay was defined as the period from the occurrence of red flags to diagnosis of EIMs. Survival curves were plotted for assessing the differences in terms of diagnostic delay and time to treatment between IMID-C and SO-C within 18 months. Results We enrolled 238 IBD patients; 127 were referred to the IMIDs Clinic Group (IMID-G) and 111 to the Standard Outpatient Clinic group (SO-C). Demographic details are summarised in Table 1. The average time to EIMs diagnosis was 2,48±1,8 months for IMID-C and 5,36±2,3 months for SO-C (p=0.005). In both groups, most patients (38,6% in IMID-C and 44 in SO-C) referred red flags for peripheral arthritis (PA). In IMID-C, chronic back pain was reported by 23,6% of patients, similarly in SO-C 27,9% had chronic back pain. Overall, the majority of patients received a diagnosis of PA (IMID-C=37,5%; SO-C=33,7%) and spondyloarthropathy (IMID-C=32,1%; SO-C=33,7%). Significantly, more patients in the IMID-C group (34, 26,8%) received treatment with immunomodulators in addition to their ongoing therapy compared to the SO-C group (17, 17,3%; p=0.04). Details of therapeutic strategies are summarized in Table 2. Survival curves revealed a significant reduction of diagnostic delay and time to therapy in IMID-C compared to SOC-C group (log-rank test, p<0.001) Conclusion Attending a dedicated IMIDs clinic can enhance the diagnostic process for EIMs in IBD patients, thereby reducing diagnostic delays. Disease-modification trials are eagerly awaited to assess the long-term impact on disease progression, quality of life and disability

gastroenterology & hepatology
Su1301 Incidence and Phenotype of Inflammatory Bowel Disease from 2012-2013 Across 9 Countries in Asia: Results from the 2012 Access Inception Cohort

Siew C. Ng,Zhirong Zeng,Minhu Chen,Whitney Tang,H. J. de Silva,Madunil A. Niriella,Yasith Udara Senanayake,Hong Yang,Jia M. Qian,Hon Ho Yu,Mo Fong Li,Jinwen Zhang,Ka Kei Ng,David E. Ong,Khoon-Lin Ling,Khean Lee Goh,Ida Hilmi,Pises Pisespongsa,Satimai Aniwan,Julajak Limsrivilai,Sathaporn Manatsathit,Murdani Abdullah,Marcellus Simadibrata,Jeffri A. Gunawan,Vui Heng Chong,Steve Tsang,Kam Hon Chan,Fu Hang Lo,Aric J. Hui,Chung Mo Chow,Michael A. Kamm,Pinjin Hu,Jessica Ching,Francis K. L. Chan,Joseph J. Y. Sung

DOI: https://doi.org/10.1016/s0016-5085(15)31572-9

IF: 29.4

2015-01-01

Gastroenterology

Abstract:Purpose:We aimed to study whether disease duration influences the healthcare costs in inflammatory bowel disease (IBD) patients in a large cohort.Methods: A large number of IBD patients from academic and non-academic hospitals were prospectively followed for two years (the COIN-study).At baseline, the disease duration of all patients was calculated.Used healthcare resources, disease activity and quality of life were assessed using threemonthly questionnaires.Healthcare resources were multiplied by their unit prices to obtain costs.These parameters were cross-sectionally compared between patients with a short (0- 1 yr), median (1-5 yrs), long (5-10 years) andextended (10-20 yrs and>20 years) disease duration at baseline.Results: A total of 3,030 patients (1,558 Crohn's disease (CD), 1,054 ulcerative colitis (UC) and 418 IBD-unspecified) were enrolled in the study.Fifty-six patients had a disease duration of 0-1 years, 502 of 1-5 years, 569 of 5-10 years, 899 of 10-20 years and 998 of over 20 years.The proportion of patients with active disease gradually decreased over time, being 30.4% in IBD patients with a short disease duration, and 13.2% in those with an extended (>20 yrs) disease duration (CD: from 36.0%to11.8%;UC: from 21.1% to 16.5%).The total IBD healthcare costs peaked at 1-5 years of disease duration, which was mainly due to a high number of TNF-α inhibitor users (CD: 30.7% vs. 17.7% after 20 years; UC: 5.7% vs. 3.4% after 20 years).In patients with a longer disease duration, total healthcare costs were lower than in the first years after diagnosis.In CD, healthcare costs after the first year following the diagnosis shifted from hospitalizations to medication costs (TNF-α-inhibitors).Hereafter, medication costs remained the major driver of total healthcare costs.In UC, total healthcare costs decreased over time, but increased again in patients with a disease duration of 20yrs or more, due to an increase of hospitalizations.The quality of life was lowest in patient shortly after diagnosis of IBD and increased gradually in both CD and UC patients with a longer disease duration (median IBD-questionnaire: CD from 175 to 179; UC from 179 to 190).Conclusions: The healthcare costs of IBD peak in patients with a short disease duration.The quality of life is higher in patients with a longer disease duration.
Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use

Ho Suk Kang,Kang Moon Lee,Ji Min Lee,Yoon Jae Kim,Hyuk Yoon,Hyun Joo Jang,Ja-Seol Koo,Dae-Bum Kim

DOI: https://doi.org/10.3748/wjg.v25.i8.989

IF: 5.374

2019-02-28

World Journal of Gastroenterology

Abstract:Ulcerative colitis (UC) is an uncommon inflammatory bowel disease (IBD). However, its incidence has recently increased in South Korea. Moreover, UC diagnoses are frequently delayed, and the relationship between diagnostic delay and UC prognosis has not been extensively studied in South Korean patients.To identify meaningful diagnostic delay affecting UC prognosis and to evaluate risk factors associated with diagnostic delay in South Korean patients.Medical records of 718 patients with UC who visited the outpatient clinic of six university hospitals in South Korea were reviewed; 167 cases were excluded because the first symptom date was unknown. We evaluated the relationship between the prognosis and a diagnostic delay of 3, 6, 12, 18, and 24 mo by comparing the prognostic factors [anti-tumor necrosis factor (TNF)-α use, admission history due to acute flare-ups, frequent admission due to flare-ups, surgery associated with UC, and the clinical remission state at the latest follow-up] at each diagnostic interval.The mean diagnostic interval was 223.3 ± 483.2 d (median, 69 d; 75 percentile, 195 d). Among the prognostic factors, anti-TNFα use was significantly increased after a diagnostic delay of 24 mo. Clinical risk factors predictive of a 24-mo diagnostic delay were age < 60 years at diagnosis [odd ratio (OR) = 14.778, 95% confidence interval (CI): 1.731-126.121], smoking history (OR = 2.688, 95%CI: 1.239-5.747, 0.012), and misdiagnosis of hemorrhoids (OR = 11.066, 95%CI: 3.596-34.053). Anti-TNFα use was associated with extensive UC at diagnosis (OR = 3.768, 95%CI: 1.860-7.632) and 24-mo diagnostic delay (OR = 2.599, 95%CI: 1.006-4.916).A diagnostic delay > 24 mo was associated with increased anti-TNFα use. Age < 60 years at diagnosis, smoking history, and misdiagnosis of hemorrhoids were risk factors for delayed diagnosis.

gastroenterology & hepatology
Clinical procedures used to diagnose inflammatory bowel disease: real-world evidence from a Danish nationwide population-based study

Nathalie Fogh Rasmussen,Anders Green,Kristine Højgaard Allin,Aske T Iversen,Gunvor Iben Madsen,Andreas Kristian Pedersen,Donna Lykke Wolff,Tine Jess,Vibeke Andersen

DOI: https://doi.org/10.1136/bmjgast-2022-000958

Abstract:Objective: Although clinical guidelines exist, the diagnostic work-up for diagnosing inflammatory bowel disease (IBD) is complex and varies in clinical practice. This study used real-life data to characterise the current diagnostic procedures used to establish IBD diagnoses in a Danish nationwide setting. Design: Person-level data on patients diagnosed with IBD between 1 January 2014 and 30 June 2018 were linked between Danish health registers. Information on age, sex, registration of other gastrointestinal diseases, and diagnostic procedures (endoscopies, biopsies, and imaging) performed in relation to the first IBD hospital admission was analysed for the total study population and was stratified by IBD type, sex, and age. Results: The majority of the 12 871 patients with IBD included underwent endoscopy (84%), had a biopsy taken (84%), and/or underwent imaging procedures (44%). In total, 7.5% of the population (6% for Crohn's disease and 8% for ulcerative colitis) were diagnosed with IBD despite not undergoing any of these diagnostic procedures. Patients with Crohn's disease underwent more procedures than patients with ulcerative colitis (94% vs 92%, p<0.001). Children underwent slightly fewer diagnostic procedures than adults (92% vs 93%, p=0.004). Slightly more men underwent at least one procedure than women (92% vs 94%, p<0.001). Conclusion: For 7.5% of patients with IBD, this study did not detect any registrations of the recommended diagnostic procedures for establishing an IBD diagnosis. Further research is needed to examine whether these findings are mainly explained by limitations of the register data or also indicate shortcomings of the general approach to IBD.
Risk Factors of Diagnostic Delay of Crohn's Disease and Their Impact on Prognosis

Li Yuan,Ren Jian'an,Wu Xiuwen,Li Jieshou

DOI: https://doi.org/10.3760/cma.j.issn.1673-9752.2015.07.019

2015-01-01

Abstract:With the rise of the incidence of Crohn's disease,clinicians began to recognize and pay attention to this disease.There is no effective method to cure the Crohn's disease currently,and the complications of the Crohn's disease are numerous and complex.Therefore,early diagnosis and treatment are very important.Due to many factors,the problen of diagnostic delay is widespread.Female patients diagnosed younger than 40 years old,the presence of ileal disease,use of non-steroidal anti-inflammatory agents,smoking history,parental symptoms are risk factors of diagnostic delay of Crohn's disease.Delayed diagnosis might increase the risk of complications,especially intestinal stenosis and operation-related complications.Crohn's disease needs to be early diagnosed and treated to improve the prognosis of patients.
Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

Imke Redeker,Johanna Callhoff,Falk Hoffmann,Hildrun Haibel,Joachim Sieper,Angela Zink,Denis Poddubnyy

DOI: https://doi.org/10.1093/rheumatology/kez090

2019-09-01

Abstract:Objectives: The objective of this study was to assess the current diagnostic delay in axial SpA (axSpA) and to analyse factors associated with it. Methods: A stratified sample of subjects with a diagnosis of axSpA (International Classification of Diseases, 10th Revision code M45) was drawn from health insurance data in Germany and was questioned on disease-related, lifestyle and socio-economic characteristics. The diagnostic delay was calculated as the time from back pain onset until a diagnosis of axSpA. A multivariable linear regression analysis was performed to explore factors associated with the diagnostic delay. Results: Among 1677 patients with axSpA included in the analysis, the mean diagnostic delay was 5.7 years (median 2.3). Of those, 407 patients were diagnosed in 1996-2005 and 484 patients in 2006-2015. The mean diagnostic delay was not substantially different in both periods: 6.3 years (median 2.6) and 7.4 (2.7), respectively. Multivariable linear regression revealed that female sex [β = 1.85 (95% CI 1.06, 2.65)], negative HLA-B27 status [β = 3.61 (95% CI 2.07, 5.14)], presence of psoriasis [β = 1.40 (95% CI 0.08, 2.73)] and younger age at symptom onset [β = 1.91 (95% CI 1.53, 2.29)] were factors associated with a longer diagnostic delay. Conclusion: The diagnostic delay in axSpA is still unacceptably long. Patients who are female, young at symptom onset, HLA-B27 negative or have psoriasis have a longer diagnostic delay. Specific referral strategies might be necessary in order to decrease the diagnostic delay in patients presenting with these characteristics.
Predictors of improvement in disease activity in childhood and adolescent Crohn's disease: an analysis of age, localization, initial severity and drug therapy - data from the Saxon Registry for Inflammatory Bowel Disease in Children in Germany (2000-2014)

Jens Weidner,Michele Zoch,Ivana Kern,Ines Reinecke,Franziska Bathelt,Ulf Manuwald,Yuan Peng,Elisa Henke,Ulrike Rothe,Joachim Kugler

DOI: https://doi.org/10.1007/s00431-024-05671-8

Abstract:The escalating worldwide prevalence of Crohn's disease (CD) among children and adolescents, coupled with a trend toward earlier onset, presents significant challenges for healthcare systems. Moreover, the chronicity of this condition imposes substantial individual burdens. Consequently, the principal objective of CD treatment revolves around rapid inducing remission. This study scrutinizes the impact of age, gender, initial disease localization, and therapy on the duration to achieve disease activity amelioration. Data from the Saxon Pediatric IBD Registry in Germany were analyzed over a period of 15 years. In addition to descriptive methods, logistic and linear regression analyses were conducted to identify correlations. Furthermore, survival analyses and Cox regressions were utilized to identify factors influencing the time to improvement in disease activity. These effects were expressed as Hazard Ratios (HR) with 95% confidence intervals. Data on the clinical course of 338 children and adolescents with CD were available in the registry. The analyses showed a significant correlation between a young age of onset and the severity of disease activity. It was evident that treatment with anti-TNF (Infliximab) was associated with a more favorable prognosis in terms of the time required for improvement in disease activity. Similarly, favorable outcomes were observed with the combination therapies of infliximab with enteral nutrition therapy and Infliximab with immunosuppressants.Conclusion: Our analysis of data from the Saxon Pediatric IBD Registry revealed that the timeframe for improvement of disease activity in pediatric Crohn's disease is influenced by several factors. Specifically, patient age, treatment modality, and initial site of inflammation were found to be significant factors. The study provides important findings that underline the need for individualized treatment.

Modification of the operating microscope.

Diagnostic delay in inflammatory bowel diseases in children

Travel Time to Treating Center is Associated with Diagnostic Delay in Pediatric Inflammatory Bowel Disease

Anaesthetic premedication: aims, assessment and methods.

Survival of Staphylococcus epidermidis on the skin of patients of lepromatous leprosy.

P1108 Factors Associated with Delayed Diagnosis of Inflammatory Bowel Disease and Risk of Complications: Analysis of the Brazilian National Registry

A Shortened Diagnostic Interval and Its Associated Clinical Factors and Related Outcomes in Inflammatory Bowel Disease Patients from a Cohort Study in China

P302 Diagnostic Delayed is Associated with a Poor Prognosis in Patients with Crohn's Disease

P1127 Diagnostic delay and economic burden in IBD: a multicenter italian experience in patients treated with biologics

Diagnostic Delay in Crohn's Disease is Associated with Increased Rate of Abdominal Surgery: A Retrospective Study in Chinese Patients.

P1172 Epidemiology and initial presentation of newly diagnosed inflammatory bowel diseases in a Danish population-based inception cohort – results from the IBD Prognosis Study

Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences

P1167 Inflammatory Bowel Disease: a phenome-wide pre- and post-diagnostic association study

High Incidence and Morbidity of Clostridium Difficile Infection among Hospitalized Patients with Inflammatory Bowel Disease: A Prospective Observational Cohort Study

P1128 Reducing diagnostic delay of Extra-Intestinal Manifestations in patients with Inflammatory Bowel Disease: a comparative study between a multidisciplinary immune-mediated diseases outpatient clinic and conventional referral specialists

Su1301 Incidence and Phenotype of Inflammatory Bowel Disease from 2012-2013 Across 9 Countries in Asia: Results from the 2012 Access Inception Cohort

Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use

Clinical procedures used to diagnose inflammatory bowel disease: real-world evidence from a Danish nationwide population-based study

Risk Factors of Diagnostic Delay of Crohn's Disease and Their Impact on Prognosis

Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

Predictors of improvement in disease activity in childhood and adolescent Crohn's disease: an analysis of age, localization, initial severity and drug therapy - data from the Saxon Registry for Inflammatory Bowel Disease in Children in Germany (2000-2014)